centrally acting muscle relaxant with anticholinergic properties

2 marketed 2 in Phase 3

This page covers all centrally acting muscle relaxant with anticholinergic properties drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting reticular formation (brain stem), Monoamine oxidase; noradrenergic and serotonergic pathways.

Targets

reticular formation (brain stem) · Monoamine oxidase; noradrenergic and serotonergic pathways

Marketed (2)

Phase 3 pipeline (2)